Cigarette smoking as a risk factor for cataract and age-related macular degeneration: A review of the literature

Optometry

Volumn 74, Issue 2, 2003, Pages 99-110

  Deblack, Susan Sanders ^a  

^a NONE   (United States)

Author keywords

Cataract; Macular degeneration; Risk factors; Smoking; Tobacco

Indexed keywords

CATARACT; CATARACT EXTRACTION; CIGARETTE SMOKING; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; HEALTH CARE COST; HUMAN; MEDICAL RESEARCH; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; EPIDEMIOLOGY; RETINA MACULA DEGENERATION; SMOKING;

CATARACT; EPIDEMIOLOGIC STUDIES; HUMANS; MACULAR DEGENERATION; RISK FACTORS; SMOKING;

EID: 0037313489     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. The health consequences of smoking - cancer: a report of the Surgeon General. Rockville, Md.: U.S. Department of Health and Human Services, Office of Smoking and Health, 1982.
2. Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992;339:1268-78.
3. Centers for Disease Control. Medical-care expenditures attributable to cigarette smoking - United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43:469-72.
4. Thylerfors B. Primary eye care and the design of the WHO programme for the prevention of blindness. Int Ophthalmol 1990;14:211-9.
5. Kupfer C. Bowman lecture. The conquest of cataract: a global challenge. Trans Ophthalmol Soc UK 1985;104:1-10.
6. West SK. Who develops cataracts? Arch Ophthalmol 1991; 109:196-8.
7. Ellwein LB, Friedlin V, Marshall McBean A, et al. Use of eye care services among the 1991 Medicare population. Ophthalmology 1996;103:1732-43.
8. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993; 111:1041-9.
9. Stark WJ, Sommer A, Smith RE. Changing trends in intraocular lens implantation. Arch Ophthalmol 1989; 107:1441-4.
10. West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 1995;39:323-34.
11. Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev 1995;17:336-46.
12. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998;42:535-47.
13. The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol 1991;133:541-53.
14. Mohan M, Sperduto RD, Angra SK, et al. India-U.S. case-control study of age-related cataracts. Arch Ophthalmol 1989;107:670-6.
15. Harding JJ, van Heyningen R. Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol 1988;72:809-14.
16. Leske MC, Chylack LT, Wu S-Y. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991;109:244-51.
17. West S, Munoz B, Emmett EA, et al. Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol 1989; 107:1166-9.
18. West S, Munoz B, Schein OD, et al. Cigarette smoking and risk for progression of nuclear opacities. Arch Ophthalmol 1995;113:1377-80.
19. Flaye DE, Sullivan KN, Cullinan TR, et al. Cataracts and cigarette smoking. The City Eye Study. Eye 1989;3:379-84.
20. Cumming RG, Mitchell P. Alcohol, smoking, and cataracts. The Blue Mountains Eye Study. Arch Ophthalmol 1997;115:1296-303.
21. Roy H. Cigarette smoking and risk of cataract [letter]. JAMA 1993;269:748.
22. Klein BE, Klein R, Linton KP, et al. Cigarette smoking and lens opacities: The Beaver Dam Eye Study. Am J Prev Med 1993;9:27-30.
23. Klein BE, Klein R, Moss SE. Incident cataract surgery. The Beaver Dam Eye Study. Ophthalmology 1997;104:573-80.
24. Delcourt C, Cristol J-P, Tessier F, et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts. The POLA Study. Am J Epidemiol 2000;151:497-504.
25. Hiller R, Sperduto RD, Podgor MJ, et al. Cigarette smoking and the risk of development of lens opacities. The Framingham Studies. Arch Ophthalmol 1997;115:1113-8.
26. Christen WG, Manson JE, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA 1992;268:989-93.
27. Hankinson SE, Willett WC, Colditz GA, et al. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA 1992;268:994-8.
28. Christen WG, Glynn RJ, Ajani UA, et al. Smoking cessation and risk of age-related cataract in men. JAMA 2000;284;713-6.
29. Weintraub JM, Willett WC, Rosner B, et al. Smoking cessation and risk of cataract extraction among U.S. women and men. Am J Epidemiol 2002;155:72-9.
30. Hammond BR, Wooten BR, Nanez JE, et al. Smoking and lens optical density. Ophthalmol Physiol Opt 1999;19:300-5.
31. Bunce GE, Kinoshita J, Horwitz J. Nutritional factors in cataract. Ann Rev Nutr 1990;10:233-54.
32. Ross MA, Crosley LK, Brown KM, et al. Plasma concentrations of carotenoids and antioxidant vitamins in Scottish males: influences of smoking. Eur J Clin Nutr 1995;49:861-5.
33. Christen WG. Antioxidants and eye disease. Am J Med 1994;97:14S-17S.
34. Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. AREDS Report No. 9. Arch Ophthalmol 2001;119:1439-52.
35. Ramakrishnan S, Sulochana KN, Selvaraj T, et al. Smoking of beedies and cataract: cadmium and vitamin C in the lens and blood. Br J Ophthalmol 1995;79:202-6.
36. Harding JJ. Cigarette smoking and risk of cataracts [letter]. JAMA 1993;269:747.
37. Paik DC, Dillon J. The nitrite/alpha crystallin reaction: a possible mechanism in lens matrix damage. Exp Eye Res 2000;70:73-80.
38. West S. Does smoke get in your eyes? JAMA 1992;268: 1025-6.
39. Friedman DS, Congdon N, Kempen J, et al. Vision problems in the U.S. Prevalence of adult vision impairment and age-related eye disease in America. Schaumberg, Ill.: National Eye Institute, National Institutes of Health and Prevent Blindness America, 2002:1-36.
40. Vingerling JR, Klaver CW, Hoffman A, et al. Epidemiology of age-related maculopathy. Epidemiol Rev 1995; 17:347-60.
41. Klein R, Wang Q, Klein BK, et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
42. Klein R, Klein BK, Linton KP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.
43. Klein R, Klein BK, Jensen SC, et al. The five-year incidence and progression of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
44. Paetkau ME, Boyd TS, Grace M, et al. Senile disciform macular degeneration and smoking. Can J Ophthalmol 1978;13:67-71.
45. Hyman LG, Lilienfeld AM, Ferris FL III, et al. Senile macular degeneration: a case-control study. Am J Epidemiol 1983;118:213-27.
46. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33-41.
47. Blumenkranz MS, Russell SR, Robey MG, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552-8.
48. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 1979;11:1197-1201.
49. West SK, Rosenthal FS, Bressler NM, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989;107:875-9.
50. Hirvela H, Luukinen H, Laara E, et al. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996;103:871-7.
51. Klein R, Klein BK, Jensen SC, et al. Age-related maculopthy in a multiracial United States population. The National Health and Nutrition Examination Survey III. Ophthalmology 1999;106:1056-65.
52. Chan D. Cigarette smoking and age-related macular degeneration. Optom Vis Sci 1998;75:476-84.
53. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701-8.
54. Tamakoshi A, Yuzawa M, Matsui M, et al. Smoking and neovascular form of age-related macular degeneration in late middle-aged males: findings from a case-control study in Japan. Br J Ophthalmol 1997;81:901-4.
55. Age-related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the Age-related Eye Disease Study: Age-related Eye Disease Study Report Number 3. Ophthalmology 2000;107:2224-32.
56. Vinding T, Appleyard M, Nyboe J, et al. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1,000 aged individuals. Acta Ophthalmol 1992;70:66-72.
57. Delcourt C, Diaz J-L, Ponton-Sanchez A, et al. Smoking and age-related macular degeneration. The POLA Study. Arch Ophthalmol 1998;116:1031-5.
58. McCarty CA, Mukesh BN, Fu CL, et al. Risk factors for age-related maculopathy. The Visual Impairment Project. Arch Ophthalmol 2001;119:1455-62.
59. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986;104:503-12.
60. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997;115:741-7.
61. Klein R, Klein BK, Linton KP, et al. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993;137:193-200.
62. Klein R, Klein BK, Moss SE. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 1998;147:103-10.
63. Vingerling JR, Hofman A, Grobbee DE, et al. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 1996;114:1193-6.
64. Klaver CW, Assink JM, Vingerling JR, et al. Smoking is also associated with age-related macular degeneration in persons aged 85 years and older: The Rotterdam Study [letter]. Arch Ophthalmol 1997;115:945.
65. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1518-23.
66. Mitchell P, Wang JJ, Smith W, et al. Smoking and the incidence of age-related maculopathy lesions: The Blue Mountains Eye Study. IOVS 2000;41:615.
67. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology 2001;108:697-704.
68. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1994;101:1522-8.
69. Seddon JM, Willett WC, Speizer FE, et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996;276:1141-6.
70. Christen WG, Glynn RJ, Manson JE, et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996;276:1147-51.
71. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995; 142:404-9.
72. Tamaki Y, Araie M, Nagahara M, et al. Acute effects of cigarette smoking on tissue circulation in human-optic nerve head and choroid-retina. Ophthalmology 1999; 106:564-9.
73. Kaiser HJ, Schoetzau A, Flammer J. Blood flow velocity in the extraocular vessels in chronic smokers. Br J Ophthalmol 1997;81:133-5.
74. Steigerwalt RD Jr, Laurora G, Incandela L, et al. Ocular and orbital blood flow in cigarette smokers. Retina 2000; 20:394-7.
75. Friedman E, Krupsky S, Lane AM, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 1995;102:640-6.
76. Beatty S, Koh H-H, Henson D, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115-34.
77. Weiter JJ. Macular degeneration. Is there a nutritional component? Arch Ophthalmol 1988;106:183-4.
78. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-203.
79. Stryker WS, Kaplan LA, Stein EA, et al. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 1988;127:283-96.
80. Wei W, Kim Y, Boudreau N. Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994. Am J Public Health 2001; 91:258-64.
81. Farchi S, Forastiere F, Pistelli R, et al. Exposure to environmental tobacco smoke is associated with lower plasma B-carotene levels among nonsmoking women married to a smoker. Cancer Epidemiol Biomarkers Prev 2001;10:907-9.
82. Hammond BR Jr, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res 1996;36:3003-9.
83. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994;272:1413-20.
84. Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 2001;119: 1417-36.
85. Centers for Disease Control. Cigarette smoking among adults - United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:869-72.
86. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking. JAMA 1999;281:72-6.
87. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical practice guideline. Rockville, Md.: U.S. Department of Health and Human Services. Public Health Service. June 2000.
88. Solberg LI, Boyle RG, Davidson G, et al. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clin Proc 2001;76:138-43.
89. U.S. Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411, 1989.